Jefferson University Hospitals

Physician Profile

Adam Dicker, MD, PhD, FASTRO

Jefferson University Physician

Academic Title: Professor
Sr. VP and Chair, Enterprise Radiation Oncology
Professor of Radiation Oncology, Pharmacology & Experimental Therapeutics

Specialties
Radiation Oncology
Radiation Oncology - Bladder Cancer
Radiation Oncology - Brain Tumor
Radiation Oncology - Kidney Cancer
Radiation Oncology - Prostate Cancer
Radiation Oncology - Testicular Cancer
Radiation Oncology - Uveal Melanoma

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
Bodine Center, Suite G-301
111 South 11th Street
Philadelphia PA 19107
Phone: (215) 955-6702
Fax: (215) 955-0412

Medical Services

Years in Practice

21

Board Certifications

  • Radiation Oncology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016,2015,2014,2013,2012,2011,2010

Personal Statement

I provide personalized medicine using the latest developments in individualized genomic health. Each patient is treated as a family member.

Education

  • Cornell University Medical College, Medical School

Internship

  • Lenox Hill Hospital, NY

Residency

  • Memorial Sloan-Kettering Cancer Center

Fellowship

  • Memorial Sloan-Kettering Cancer Center

Recent Publications

Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases

IGFBP3 modulates lung tumorigenesis and cell growth through IGF1 signaling

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model

Individual patient-level meta-Analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease

Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery

Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer

RB loss promotes prostate cancer metastasis

Reaffirming and clarifying the American Society of Clinical Oncology's policy statement on the critical role of phase i trials in cancer research and treatment

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

Dosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcsDosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcs

Patient-level DNA damage and repair pathway profiles and prognosis after prostatectomy for high-risk prostate cancer

Closed loop control of a robot assisted smart flexible needle for percutaneous intervention

Reply to C.G. Rusthoven et al

Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data

Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy

Radiation therapy after radical prostatectomy for prostate cancer: Evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort